Benitec Biopharma Inc. (BNTC) vs Embecta Corp. (EMBC)
A side-by-side comparison of Benitec Biopharma Inc. and Embecta Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BNTC
Benitec Biopharma Inc.
$8.77HealthcareDelayed quote: Oct 6, 2026, 11:54 AM EDT
EMBC
Embecta Corp.
$6.01HealthcareDelayed quote: Oct 6, 2026, 11:55 AM EDT
Total return — BNTC vs EMBC
growth of $100 · dividends reinvested · last 5yBNTC -74.4% (-23.8%/yr)EMBC -85.5% (-32.1%/yr)BNTC compounded faster over this window
BNTC EMBC
BNTC vs EMBC: by the numbers
- •EMBC is the larger company ($356M vs $301M market cap).
- •EMBC is profitable (8.59% net margin) while BNTC runs a net loss (0.00%).
- •EMBC pays a dividend (5.44% yield), while BNTC is a former payer with no current dividend run rate.
Metrics side by side
Valuation
| Metric | BNTC | EMBC |
|---|---|---|
| P/E ratio | N/A | 4.06 |
| Forward P/E | N/A | 3.41 |
| P/S ratio | N/A | 0.35 |
| P/B ratio | 1.70 | N/A |
| EV / EBITDA | N/A | 5.39 |
| FCF yield | N/A | 46.20% |
Profitability
| Metric | BNTC | EMBC |
|---|---|---|
| Gross margin | 0.00% | 59.89% |
| Operating margin | 0.00% | 24.85% |
| Net margin | 0.00% | 8.59% |
| ROE | -25.73% | N/A |
| ROIC | -28.88% | 17.99% |
Dividends
| Metric | BNTC | EMBC |
|---|---|---|
| Dividend yield | N/A | 5.44% |
| Payout ratio | N/A | 21.62% |
Growth (annualized)
| Metric | BNTC | EMBC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -0.09% |
| EPS CAGR (5Y) | N/A | -26.22% |
| FCF CAGR (5Y) | N/A | -16.77% |
| Total return CAGR (5Y) | -31.08% | N/A |
Frequently asked
- Does BNTC or EMBC pay a bigger dividend?
- EMBC pays a dividend (5.44% yield), while BNTC is a former payer with no current dividend run rate.
- Is BNTC or EMBC more profitable?
- EMBC runs the higher net margin — BNTC at 0.00% versus EMBC at 8.59%.
Go deeper
Dig into the metrics
Embecta P/E ratioEmbecta dividend yieldBenitec Biopharma ROEEmbecta ROEBenitec Biopharma operating marginEmbecta operating marginBenitec Biopharma revenue growthEmbecta revenue growthBenitec Biopharma free cash flowEmbecta free cash flow
Benitec Biopharma & Embecta appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.